Showing results (41-50 of 491) with videos related to
Sort By:
Pageof 50
Clinical Neuropharmacology|August 1, 1989
Cardiovascular effects of lisuride continuous intravenous infusion in fluctuating Parkinson's diseaseA Capria, A Attanasio, M Quatrana, et al.Rivista Di Neurologia|November 1, 1991
[Changes in the nigrostriatal dopamine receptor compartment after continuous dopaminergic infusions in Parkinson disease]F Baronti, S Ruggieri, M M Mouradian, et al.Journal of Neural Transmission. Supplementum|January 1, 1988
Subcutaneous lisuride infusion in Parkinson's disease: clinical results using different modes of administrationF Stocchi, S Ruggieri, A Antonini, et al.Movement Disorders : Official Journal of the Movement Disorder Society|January 1, 1992
Intravenous boluses and continuous infusions of L-dopa methyl ester in fluctuating patients with Parkinson's diseaseF Stocchi, S Ruggieri, A Carta, et al.Clinical Neuropharmacology|June 1, 1991
The clinical efficacy of oral levodopa methyl ester solution in reversing afternoon "off" periods in Parkinson's diseaseM J Steiger, F Stocchi, A Carta, et al.Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology|July 19, 2001
The prolonged cortical silent period in patients with Huntington's diseaseN Modugno, A Currà, M Giovannelli, et al.European Journal of Physical and Rehabilitation Medicine|May 10, 2012
The relation between Parkinson's disease and ageing. Comparison of the gait patterns of young Parkinson's disease subjects with healthy elderly subjectsP Sale, M F De Pandis, S L Vimercati, et al.European Journal of Neurology|September 22, 2020
Overnight switch from rasagiline to safinamide in Parkinson's disease patients with motor fluctuations: a tolerability and safety studyF Stocchi, L Vacca, P Grassini, et al.Clinical Neuropharmacology|February 1, 1994
Comparison between a fast and a slow release preparation of levodopa and a combination of the two: a clinical and pharmacokinetic studyF Stocchi, N P Quinn, L Barbato, et al.International Journal of Clinical Practice|February 3, 2006
Rasagiline: defining the role of a novel therapy in the treatment of Parkinson's diseaseF StocchiPageof 50